RecruitingNot ApplicableNCT03346694

Reducing Surgical Site Infection Rates Using an Alternative Sternal Dressing


Sponsor

Stanford University

Enrollment

660 participants

Start Date

May 1, 2018

Study Type

INTERVENTIONAL

Conditions

Summary

This study will evaluate two alternative dressings compared to a standard Island dressing presently in use at Stanford Hospital to determine reductions in surgical site infection (SSI) rates among cardiac surgery patients. Cardiovascular surgery patients who will have a sternotomy incision as a routine part of their surgery will be approached to voluntarily participate. Participants will be randomized to one of three dressing to determine which dressing has the lowest rate of sternal wound infection. The investigators will also assess the impact of alternative dressing use on hospital 30-day readmission rates related to SSI.


Eligibility

Min Age: 18 Years

Exclusion Criteria1

  • Patients undergoing heart transplants, Ventricular Assist Device (VAD), with postoperative courses complicated by tamponade, take-backs, and open chest incisions will also be excluded.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEStandard Island Dressing

participant randomized to control group before end of surgery to be applied on cardiovascular heart surgical sternal incision.

DEVICEPrevena Negative Pressure wound dressing

participant randomized to dressing before end of surgery to be applied on cardiovascular heart surgical sternal incision.

DEVICEMepilex Border Post-Op Ag

Participant randomized to dressing before end of surgery to be applied on cardiovascular heart surgical sternal incision


Locations(1)

Stanford Healthcare

Stanford, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03346694


Related Trials